Neurotoxin-based models of Parkinson's disease

J Bové, C Perier - Neuroscience, 2012 - Elsevier
Animal experimentation in the Parkinson's disease (PD) field is a classic example of how the
use of animal models to study diseases can have a significant impact on human health …

Animal models of Parkinson's disease: an empirical comparison with the phenomenology of the disease in man

M Gerlach, P Riederer - Journal of neural transmission, 1996 - Springer
Animal models are an important aid in experimental medical science because they enable
one to study the pathogenetic mechanisms and the therapeutic principles of treating the …

Animal models of Parkinson's disease: a guide to selecting the optimal model for your research

J Lama, Y Buhidma, EJR Fletcher, S Duty - Neuronal Signaling, 2021 - portlandpress.com
Parkinson's disease (PD) is a complex, multisystem disorder characterised by α-synuclein
(SNCA) pathology, degeneration of nigrostriatal dopaminergic neurons, multifactorial …

The serotonergic system in Parkinson's disease

P Huot, SH Fox, JM Brotchie - Progress in neurobiology, 2011 - Elsevier
Although the cardinal manifestations of Parkinson's disease (PD) are attributed to a decline
in dopamine levels in the striatum, a breadth of non-motor features and treatment-related …

Cholinergic–serotonergic imbalance contributes to cognitive and behavioral symptoms in Alzheimer's disease

M Garcia-Alloza, FJ Gil-Bea, M Diez-Ariza… - Neuropsychologia, 2005 - Elsevier
Neuropsychiatric symptoms seen in Alzheimer's disease (AD) are not simply a consequence
of neurodegeneration, but probably result from differential neurotransmitter alterations …

Compensatory mechanisms in experimental and human parkinsonism: towards a dynamic approach

E Bezard, CE Gross - Progress in neurobiology, 1998 - Elsevier
This paper provides an overview of the compensatory mechanisms which come into action
during experimental and human parkinsonism. The intrinsic properties of the dopaminergic …

[HTML][HTML] Visualization of monoaminergic neurons and neurotoxicity of MPTP in live transgenic zebrafish

L Wen, W Wei, W Gu, P Huang, X Ren, Z Zhang… - Developmental …, 2008 - Elsevier
We describe an enhancer trap transgenic zebrafish line, ETvmat2: GFP, in which most
monoaminergic neurons are labeled by green fluorescent protein (GFP) during embryonic …

Serotonin and Parkinson's disease: On movement, mood, and madness

SH Fox, R Chuang, JM Brotchie - Movement disorders: official …, 2009 - Wiley Online Library
An appreciation of the multiple roles that serotonin (5‐HT) may play in Parkinson's disease
(PD) has increased in recent years. Early pathological studies in PD demonstrated …

Social vs. environmental stress models of depression from a behavioural and neurochemical approach

E Venzala, AL Garcia-Garcia, N Elizalde… - European …, 2013 - Elsevier
Major depression is a mental disorder often preceded by exposure to chronic stress or
stressful life events. Recently, animal models based on social conflict such as chronic social …

The MPTP-lesioned non-human primate models of Parkinson's disease. Past, present, and future

SH Fox, JM Brotchie - Progress in brain research, 2010 - Elsevier
Non-human primate (NHP) models of Parkinson's disease (PD) have been essential in
understanding the pathophysiology and neural mechanisms underlying PD. The most …